FIELD: chemistry.
SUBSTANCE: present invention relates to a crystalline salt of 1,2-ethanedisulfonic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinoline-5-yl)ethylamino]methyl} -5- methoxyphenylcarbamoyl)ethyl]piperadin-4-yl ether biphenyl-2-ylcarbamic acid or its solvate. The invention also relates to a pharmaceutical composition containing such a salt, a combination containing the salt in paragraph 1 and a steroid anti-inflammatory agent, a method of treating pulmonary disorder, a method of producing the salt in paragraph 1 and use of the salt in paragraph 1 in making a medicinal agent.
EFFECT: novel crystalline salt of the compound given above, having useful biological properties, is obtained.
34 cl, 6 dwg, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIPHENYL DERIVATIVES | 2004 |
|
RU2330841C2 |
| DIAMIDE COMPOUNDS HAVING ACTIVITY OF MUSCARINIC RECEPTOR ANTAGONIST AND ACTIVITY OF β ADRENERGIC RECEPTOR AGONIST | 2010 |
|
RU2676686C2 |
| DIAMIDE COMPOUNDS POSSESSING MUSCARINIC ANTAGONIST ACTIVITY AND B2 ADRENERGIC RECEPTOR B2 AGONIST ACTIVITY | 2010 |
|
RU2543716C2 |
| BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS | 2005 |
|
RU2366656C2 |
| DERIVANTS OF BICYCLO[2, 2, 1] HEPT-7-YLAMINE AND THEIR APPLICATIONS | 2006 |
|
RU2442771C2 |
| BENZAMIDE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS OF SAID DERIVATIVES, PHARMACEUTICAL COMPOSITION BASED THERE ON AND APPLICATION THEREOF | 2004 |
|
RU2333198C2 |
| COMPOUNDS HAVING ANTAGONISTIC ACTIVITY TOWARDS MUSCARINIC RECEPTORS AND AGONIST ACTIVITY TO BETA2-ADRENORECEPTORS | 2012 |
|
RU2606121C2 |
| COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA-2-ADRENERGIC RECEPTOR AGONIST ACTIVITY | 2013 |
|
RU2661877C2 |
| CLASS OF BIFUNCTIONAL COMPOUNDS WITH QUATERNARY AMMONIUM SALT STRUCTURE | 2017 |
|
RU2722720C1 |
| DERIVATIVES OF 4-PIPERIDINYLALKYLAMINE AND PHARMACEUTICAL COMPOSITION POSSESSING ANTAGONISTIC AFFECT ON MUSCARINIC RECEPTOR | 2002 |
|
RU2300524C2 |
